Neuroone Medical Technologies (NMTC) Cash from Operations Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.78% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 9.30% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 20.35% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 22.35% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -48.14% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.50% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 50.11% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -14.75% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.83% |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn | 27.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.94% |
| Dec 31, 2025 | 3.73% |
| Sep 30, 2025 | -51.81% |
| Jun 30, 2025 | 17.82% |
| Mar 31, 2025 | 74.07% |
| Dec 31, 2024 | 27.60% |
| Sep 30, 2024 | -9.53% |
| Jun 30, 2024 | -1.02% |
| Mar 31, 2024 | 2.95% |
| Dec 31, 2023 | -26.00% |
| Sep 30, 2023 | -132.98% |
| Jun 30, 2023 | -33.97% |
| Mar 31, 2023 | -41.63% |
| Dec 31, 2022 | -41.80% |
| Sep 30, 2022 | 42.45% |
| Jun 30, 2022 | -16.29% |
| Jun 30, 2021 | -6.54% |
| Mar 31, 2021 | -59.07% |
| Dec 31, 2020 | -47.09% |
| Sep 30, 2020 | 34.94% |
| Jun 30, 2020 | -29.56% |
| Mar 31, 2020 | -52.73% |
| Dec 31, 2019 | -91.00% |
| Sep 30, 2019 | -420.74% |
| Jun 30, 2019 | -488.90% |
| Jun 30, 2018 | -1,124.18% |
| Mar 31, 2018 | -211.35% |
| Jun 30, 2017 | -1,362.10% |
| Mar 31, 2017 | -2,312.25% |
| Dec 31, 2016 | -308.27% |
| Sep 30, 2016 | 55.16% |
| Jun 30, 2016 | 17.82% |
| Dec 31, 2015 | -66.88% |
| Sep 30, 2015 | 10.65% |
| Jun 30, 2015 | 23.29% |
| Mar 31, 2015 | -52.55% |
| Jun 30, 2014 | 29.11% |
| Mar 31, 2014 | 84.46% |
| Dec 31, 2013 | -67.77% |
| Sep 30, 2013 | 0.25% |